Episodes

In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host Raman Sehgal, Founder & Global President at ramarketing, Laura Child, CRO Sector Lead at ramarketing, Erik Haeffler, VP Manufacturing Services & Head of Sustainability at Recipharm AB, Dan Stanton, Founder and Editor of Bioprocess Insider …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Shane Needham, Chief Founding Scientist, Director of the Board and Owner at Alturas Analytics, Inc. With a PHD in chemistry, Dr. Needham has spent almost 30 years in the sector. He started his career at …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jason Lacombe, CEO at Veratrak. A graduate of Toronto and Oxford University, Jason was recently named as one of Forbes 30 Under 30 and has also advised the WHO and EU. Today, his business is …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mary Christian, Senior Vice President, Regulatory at Lyndra Therapeutics. To say Mary has an impressive track record is an understatement. Across the last three decades she has worked for some of the biggest pharmaceutical companies …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Sara Lesina, Global Marketing Director of Pharma & Nutrition, Capsules and Health Ingredients at Lonza. A multilingual, international marketing leader, Sara oversees the global marketing and product line management team for the capsule business of Lonza, Capsugel®. Your host, …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Carl-Åke Carlsson CEO at Xellia Pharmaceuticals. Like celebrated “one-club” football stars like Leo Messi at Barcelona, Alessandro Del Piero at Juventus and Steven Gerrard at Liverpool… Carl-Åke has been with Xellia since 1988. A pharmaceutical …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Manuel Leal, Business Development Director at IDIFARMA. A student of law and business, Manuel has carved a very impressive career in the outsourcing space all despite having no formal pharma and science background! He has …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Claire Thompson, CEO and Founder at Agility Life Sciences. Claire is an award winning pharmaceutical scientist with over 20 years of experience in developing pharma products, global companies, virtual biotechs and CROs. Today, Claire consults …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kevin Orfan, President at Sharp. Kevin has been in the pharmaceutical and medical device industry for over 30 years and has incredible experience in the contract manufacturing space. He began his pharma career at Abbott …

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jeffrey Kiplinger, Co-Founder of Cohere Business Strategies and advisor and coach for entrepreneurs in the life sciences space. Jeffrey Co-Founded Research Operations Group in 2000, founded Averica Discovery Services in 2007, and has over 35 …